Astragaloside IV Exerts Cognitive Benefits and Promotes Hippocampal Neurogenesis in Stroke Mice by Downregulating Interleukin-17 Expression via Wnt Pathway
BackgroundStroke remains a leading cause of adult disability and the demand for stroke rehabilitation services is growing, and Astragaloside IV (As IV), a primary bioactive compound of Radix Astragali : Astragalus mongholicus Bunge (Fabaceae), may be a promising stroke therapy.MethodsTo access the e...
Main Authors: | Li Sun, Heming Zhang, Wen Wang, Zhiyang Chen, Shuang Wang, Jiangjing Li, Guangyao Li, Changjun Gao, Xude Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00421/full |
Similar Items
-
Astragaloside IV, as a potential anticancer agent
by: Dongqin Xia, et al.
Published: (2023-02-01) -
Astragalosidic Acid: A New Water-Soluble Derivative of Astragaloside IV Prepared Using Remarkably Simple TEMPO-Mediated Oxidation
by: Lin-Sen Qing, et al.
Published: (2017-07-01) -
Pharmacological Effects of Astragaloside IV: A Review
by: Yutong Liang, et al.
Published: (2023-08-01) -
The potential molecular pathways of Astragaloside-IV in colorectal cancer: A systematic review
by: Tang Ziyang, et al.
Published: (2023-11-01) -
Research progress of astragaloside IV in the treatment of atopic diseases
by: Shencun Yu, et al.
Published: (2022-12-01)